Part 2/10:
The pandemic illuminated how a limited global readership—primarily institutions and privileged individuals—excluded many who desperately needed this knowledge, including front-line healthcare workers and researchers in developing countries. Despite the enormous public investment into research, much of the definitive data remained behind costly subscriptions, creating a paradox: taxpayers fund the research but often cannot access its findings without paying again.